The serum separation gel market size has grown strongly in recent years. It will grow from $9.66 billion in 2025 to $10.49 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising use of blood collection tubes in routine clinical diagnostics, increasing demand for reliable serum separation in biochemical and immunological testing, early availability of serum separation gel integrated with glass and plastic tubes, expansion of diagnostic laboratory infrastructure in hospitals and clinics, growing application of serum-based testing in research and biotechnology.
The serum separation gel market size is expected to see strong growth in the next few years. It will grow to $13.97 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to rising need for high-performance gel formulations for automated processing, increasing utilization of pre-filled gel packs and bulk gel for custom tube manufacturing, growing adoption of serum separation solutions in pharmaceutical and biotech r&d, expanding use of gel-based tubes in large-scale screening and blood banking, rising focus on improving sample stability accuracy and turnaround times. Major trends in the forecast period include rising adoption of serum separation gel for accurate and efficient serum isolation in diagnostic testing, increasing utilization of gel-integrated blood collection tubes across clinical and research laboratories, growing preference for powder and liquid gel formulations based on processing requirements, expansion of serum separation applications across hospitals diagnostic labs and blood banks, increasing demand for high-stability gel solutions to support reliable centrifugation and sample integrity.
The increasing demand for diagnostic testing is expected to support the growth of the serum separation gel market in the coming years. Diagnostic testing involves identifying diseases or medical conditions through the analysis of biological samples, such as blood or tissue, to determine the presence of specific markers or abnormalities. Demand for diagnostic testing is rising as it enables early disease detection, when treatment is most effective, and supports preventive healthcare by assessing risk factors and guiding timely interventions. Serum separation gel plays a critical role in diagnostic testing by separating serum from blood cells, thereby allowing precise analysis of biochemical markers and improving disease detection accuracy. For example, in November 2025, according to Today’s Clinical Lab, a US-based healthcare information platform, demand for diagnostic testing across hospitals and laboratories increased to 60% in 2025 from 55% in 2022. As a result, the growing demand for diagnostic testing is driving the expansion of the serum separation gel market.
The increasing prevalence of chronic diseases is also expected to propel growth in the serum separation gel market. Chronic diseases are long-term conditions that typically last longer than three months and often require continuous medical management or restrict daily activities. The rise in chronic diseases is attributed to aging populations, unhealthy lifestyle patterns, and advancements in medical care that allow individuals with acute conditions to live longer, thereby increasing the overall burden of long-term illnesses. Serum separation gel is commonly used in blood collection tubes to enable effective serum separation, supporting accurate diagnosis and ongoing monitoring of biomarkers associated with chronic diseases. For instance, in August 2024, according to a study published in the European Journal of Preventive Cardiology by researchers from the National University of Singapore and several international institutions, global cardiovascular disease prevalence is projected to rise by 90% between 2025 and 2050, with crude mortality increasing by 73.4%. The study estimates that cardiovascular-related deaths will reach 35.6 million in 2050, compared to 20.5 million in 2025. Consequently, the rising burden of chronic diseases is contributing to the growth of the serum separation gel market.
Companies operating in the serum separation gel market are increasingly focused on developing innovative product offerings, such as serum fast separator tubes, to strengthen their market position. A serum fast separator tube is designed with a specialized gel or clot activator additive that enables rapid separation of serum from whole blood after centrifugation. For example, in May 2023, Greiner Bio-One, an Austria-based biotechnology company, launched the VACUETTE CAT Serum Fast Separator. This product enables complete coagulation of whole blood samples in approximately five minutes, delivering a significant time advantage over conventional serum tubes. The shatter-resistant tube is internally coated with a blood clot activator and thrombin, while the integrated gel forms a stable barrier between the serum and solid blood components. The inclusion of thrombin further accelerates the clotting process, enhancing efficiency in blood sample processing.
Major companies operating in the serum separation gel market are Greiner Bio‑One International GmbH, Becton Dickinson and Company, Terumo Corporation, FL Medical S.r.l., Improve Medical Instruments Co Ltd, Sarstedt AG & Co KG, Nipro Corporation, Vitrex Medical A/S, Sunphoria Co Ltd, LABORATORIOS CONDA S.A., SEKISUI Chemical Co Ltd, Lohmann & Rauscher GmbH & Co KG, Hindustan Syringes & Medical Devices Ltd, TUDOR International Pty Ltd, Zhejiang Gongdong Medical Technology Co Ltd, Shandong Weigao Group Medical Polymer Co Ltd, Shanghai Kindly Enterprise Development Group Co Ltd, Cardinal Health Inc, BIOSIGMA S.p.A., Bio‑Rad Laboratories Inc.
North America was the largest region in the serum separation gel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the serum separation gel market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the serum separation gel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the serum separation gel market by increasing import and raw material costs for polymers, additives, chemical stabilizers, and tube components used in gel-integrated and stand-alone serum separation products, leading to higher manufacturing and procurement expenses across hospitals, diagnostic laboratories, pharmaceutical companies, and blood banks. The impact is more notable in North America, Europe, and Asia-Pacific regions that depend on cross-border sourcing of tube plastics, glass vials, packaging materials, and specialty gel ingredients for powder and liquid formulations. These higher landed costs have contributed to pricing pressure and extended purchasing cycles in cost-sensitive laboratory environments; however, tariffs are also stimulating regional manufacturing, local formulation of gel compounds, and supplier diversification, creating selective positive outcomes for domestic producers.
The serum separation gel market research report is one of a series of new reports that provides serum separation gel market statistics, including serum separation gel industry global market size, regional shares, competitors with a serum separation gel market share, detailed serum separation gel market segments, market trends and opportunities, and any further data you may need to thrive in the serum separation gel industry. This serum separation gel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Serum separation gel is a specialized substance utilized to isolate serum from whole blood samples, streamlining subsequent analysis in clinical and research environments. It is incorporated into blood collection tubes to establish a physical barrier between serum and blood cells, aiding in the separation process during centrifugation.
The primary types of serum separation gel include integrated tubes and standalone gel formulations. Integrated tubes feature blood collection tubes pre-coated or equipped with serum separation gels, simplifying serum isolation during sample collection. These formulations may include powder gel or liquid gel variations and are utilized across various sectors, including hospitals, clinics, pharmaceutical and biotechnology firms, diagnostic laboratories, and blood banks.
The serum separation gel market consists of sales of silica-based and polymer-based serum separation gels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The serum separation gel market size is expected to see strong growth in the next few years. It will grow to $13.97 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to rising need for high-performance gel formulations for automated processing, increasing utilization of pre-filled gel packs and bulk gel for custom tube manufacturing, growing adoption of serum separation solutions in pharmaceutical and biotech r&d, expanding use of gel-based tubes in large-scale screening and blood banking, rising focus on improving sample stability accuracy and turnaround times. Major trends in the forecast period include rising adoption of serum separation gel for accurate and efficient serum isolation in diagnostic testing, increasing utilization of gel-integrated blood collection tubes across clinical and research laboratories, growing preference for powder and liquid gel formulations based on processing requirements, expansion of serum separation applications across hospitals diagnostic labs and blood banks, increasing demand for high-stability gel solutions to support reliable centrifugation and sample integrity.
The increasing demand for diagnostic testing is expected to support the growth of the serum separation gel market in the coming years. Diagnostic testing involves identifying diseases or medical conditions through the analysis of biological samples, such as blood or tissue, to determine the presence of specific markers or abnormalities. Demand for diagnostic testing is rising as it enables early disease detection, when treatment is most effective, and supports preventive healthcare by assessing risk factors and guiding timely interventions. Serum separation gel plays a critical role in diagnostic testing by separating serum from blood cells, thereby allowing precise analysis of biochemical markers and improving disease detection accuracy. For example, in November 2025, according to Today’s Clinical Lab, a US-based healthcare information platform, demand for diagnostic testing across hospitals and laboratories increased to 60% in 2025 from 55% in 2022. As a result, the growing demand for diagnostic testing is driving the expansion of the serum separation gel market.
The increasing prevalence of chronic diseases is also expected to propel growth in the serum separation gel market. Chronic diseases are long-term conditions that typically last longer than three months and often require continuous medical management or restrict daily activities. The rise in chronic diseases is attributed to aging populations, unhealthy lifestyle patterns, and advancements in medical care that allow individuals with acute conditions to live longer, thereby increasing the overall burden of long-term illnesses. Serum separation gel is commonly used in blood collection tubes to enable effective serum separation, supporting accurate diagnosis and ongoing monitoring of biomarkers associated with chronic diseases. For instance, in August 2024, according to a study published in the European Journal of Preventive Cardiology by researchers from the National University of Singapore and several international institutions, global cardiovascular disease prevalence is projected to rise by 90% between 2025 and 2050, with crude mortality increasing by 73.4%. The study estimates that cardiovascular-related deaths will reach 35.6 million in 2050, compared to 20.5 million in 2025. Consequently, the rising burden of chronic diseases is contributing to the growth of the serum separation gel market.
Companies operating in the serum separation gel market are increasingly focused on developing innovative product offerings, such as serum fast separator tubes, to strengthen their market position. A serum fast separator tube is designed with a specialized gel or clot activator additive that enables rapid separation of serum from whole blood after centrifugation. For example, in May 2023, Greiner Bio-One, an Austria-based biotechnology company, launched the VACUETTE CAT Serum Fast Separator. This product enables complete coagulation of whole blood samples in approximately five minutes, delivering a significant time advantage over conventional serum tubes. The shatter-resistant tube is internally coated with a blood clot activator and thrombin, while the integrated gel forms a stable barrier between the serum and solid blood components. The inclusion of thrombin further accelerates the clotting process, enhancing efficiency in blood sample processing.
Major companies operating in the serum separation gel market are Greiner Bio‑One International GmbH, Becton Dickinson and Company, Terumo Corporation, FL Medical S.r.l., Improve Medical Instruments Co Ltd, Sarstedt AG & Co KG, Nipro Corporation, Vitrex Medical A/S, Sunphoria Co Ltd, LABORATORIOS CONDA S.A., SEKISUI Chemical Co Ltd, Lohmann & Rauscher GmbH & Co KG, Hindustan Syringes & Medical Devices Ltd, TUDOR International Pty Ltd, Zhejiang Gongdong Medical Technology Co Ltd, Shandong Weigao Group Medical Polymer Co Ltd, Shanghai Kindly Enterprise Development Group Co Ltd, Cardinal Health Inc, BIOSIGMA S.p.A., Bio‑Rad Laboratories Inc.
North America was the largest region in the serum separation gel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the serum separation gel market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the serum separation gel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the serum separation gel market by increasing import and raw material costs for polymers, additives, chemical stabilizers, and tube components used in gel-integrated and stand-alone serum separation products, leading to higher manufacturing and procurement expenses across hospitals, diagnostic laboratories, pharmaceutical companies, and blood banks. The impact is more notable in North America, Europe, and Asia-Pacific regions that depend on cross-border sourcing of tube plastics, glass vials, packaging materials, and specialty gel ingredients for powder and liquid formulations. These higher landed costs have contributed to pricing pressure and extended purchasing cycles in cost-sensitive laboratory environments; however, tariffs are also stimulating regional manufacturing, local formulation of gel compounds, and supplier diversification, creating selective positive outcomes for domestic producers.
The serum separation gel market research report is one of a series of new reports that provides serum separation gel market statistics, including serum separation gel industry global market size, regional shares, competitors with a serum separation gel market share, detailed serum separation gel market segments, market trends and opportunities, and any further data you may need to thrive in the serum separation gel industry. This serum separation gel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Serum separation gel is a specialized substance utilized to isolate serum from whole blood samples, streamlining subsequent analysis in clinical and research environments. It is incorporated into blood collection tubes to establish a physical barrier between serum and blood cells, aiding in the separation process during centrifugation.
The primary types of serum separation gel include integrated tubes and standalone gel formulations. Integrated tubes feature blood collection tubes pre-coated or equipped with serum separation gels, simplifying serum isolation during sample collection. These formulations may include powder gel or liquid gel variations and are utilized across various sectors, including hospitals, clinics, pharmaceutical and biotechnology firms, diagnostic laboratories, and blood banks.
The serum separation gel market consists of sales of silica-based and polymer-based serum separation gels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Serum Separation Gel Market Characteristics
3. Serum Separation Gel Market Supply Chain Analysis
4. Global Serum Separation Gel Market Trends and Strategies
5. Serum Separation Gel Market Analysis of End Use Industries
7. Global Serum Separation Gel Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Serum Separation Gel Total Addressable Market (TAM) Analysis for the Market
9. Serum Separation Gel Market Segmentation
10. Serum Separation Gel Market Regional and Country Analysis
11. Asia-Pacific Serum Separation Gel Market
12. China Serum Separation Gel Market
13. India Serum Separation Gel Market
14. Japan Serum Separation Gel Market
15. Australia Serum Separation Gel Market
16. Indonesia Serum Separation Gel Market
17. South Korea Serum Separation Gel Market
18. Taiwan Serum Separation Gel Market
19. South East Asia Serum Separation Gel Market
20. Western Europe Serum Separation Gel Market
21. UK Serum Separation Gel Market
22. Germany Serum Separation Gel Market
23. France Serum Separation Gel Market
24. Italy Serum Separation Gel Market
25. Spain Serum Separation Gel Market
26. Eastern Europe Serum Separation Gel Market
27. Russia Serum Separation Gel Market
28. North America Serum Separation Gel Market
29. USA Serum Separation Gel Market
30. Canada Serum Separation Gel Market
31. South America Serum Separation Gel Market
32. Brazil Serum Separation Gel Market
33. Middle East Serum Separation Gel Market
34. Africa Serum Separation Gel Market
36. Serum Separation Gel Market Competitive Landscape and Company Profiles
37. Serum Separation Gel Market Other Major and Innovative Companies
40. Serum Separation Gel Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Serum Separation Gel Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses serum separation gel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for serum separation gel? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The serum separation gel market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Serum Separation Gel Integrated With Tube; Serum Separation Gel Without Tube2) By Formulation: Powder Gel; Liquid Gel
3) By End User: Hospitals And clinics; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Blood Banks
Subsegments:
1) By Serum Separation Gel Integrated With Tube: Plastic Tubes With Serum Separation Gel; Glass Tubes With Serum Separation Gel2) By Serum Separation Gel Without Tube: Pre-filled Gel Packs; Bulk Serum Separation Gel For Custom Tubes
Companies Mentioned: Greiner Bio‑One International GmbH; Becton Dickinson and Company; Terumo Corporation; FL Medical S.r.l.; Improve Medical Instruments Co Ltd; Sarstedt AG & Co KG; Nipro Corporation; Vitrex Medical A/S; Sunphoria Co Ltd; LABORATORIOS CONDA S.A.; SEKISUI Chemical Co Ltd; Lohmann & Rauscher GmbH & Co KG; Hindustan Syringes & Medical Devices Ltd; TUDOR International Pty Ltd; Zhejiang Gongdong Medical Technology Co Ltd; Shandong Weigao Group Medical Polymer Co Ltd; Shanghai Kindly Enterprise Development Group Co Ltd; Cardinal Health Inc; BIOSIGMA S.p.A.; Bio‑Rad Laboratories Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Serum Separation Gel market report include:- Greiner Bio‑One International GmbH
- Becton Dickinson and Company
- Terumo Corporation
- FL Medical S.r.l.
- Improve Medical Instruments Co Ltd
- Sarstedt AG & Co KG
- Nipro Corporation
- Vitrex Medical A/S
- Sunphoria Co Ltd
- LABORATORIOS CONDA S.A.
- SEKISUI Chemical Co Ltd
- Lohmann & Rauscher GmbH & Co KG
- Hindustan Syringes & Medical Devices Ltd
- TUDOR International Pty Ltd
- Zhejiang Gongdong Medical Technology Co Ltd
- Shandong Weigao Group Medical Polymer Co Ltd
- Shanghai Kindly Enterprise Development Group Co Ltd
- Cardinal Health Inc
- BIOSIGMA S.p.A.
- Bio‑Rad Laboratories Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.49 Billion |
| Forecasted Market Value ( USD | $ 13.97 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
